ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

We aren’t showing our typical comparisons because the provider updated his/her primary specialty after we conducted our analysis. The updated address appears on this page.

Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,599Medicare Part D Prescriptions Filled, Including Refills
$1.13M Total Retail Price of All Prescriptions
460 Patients Receiving at Least One Drug in Part D
33%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 1,815 619 S3
FENTANYL 571 146 S2
MORPHINE SULFATE ER 558 128 S2
OXYCODONE HCL-ACETAMINOPHEN 556 139 S2
CYMBALTA 550 169
LYRICA 513 132
METHADONE HCL 491 92 S2
GABAPENTIN 413 107
OXYCODONE HCL 375 97 S2
CARISOPRODOL 318 77 R
TIZANIDINE HCL 315 53
OXYCONTIN 276 107 S2
CYCLOBENZAPRINE HCL 255 65 R
METHOCARBAMOL 229 30 R
ENDOCET 200 65 S2
TRAMADOL HCL 173 36
TRAZODONE HCL 145 42
AMITRIPTYLINE HCL 108 49 R
KADIAN 93 16 S2
SERTRALINE HCL 93 36
VENLAFAXINE HCL ER 90 32
CITALOPRAM HBR 76 22
OPANA ER 75 17 S2
SUBOXONE 74 0
BACLOFEN 68 0
OXYCODONE-ACETAMINOPHEN 67 30 S2
HYDROMORPHONE HCL 64 24 S2
ESCITALOPRAM OXALATE 60 0
NUVIGIL 60 0
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.